Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
Clinical trial NCT07045935 · RECRUITING
Trial details
- NCT number
- NCT07045935
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-16
- Primary completion
- 2029-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.